MSB 7.69% $1.19 mesoblast limited

Ann: Mesoblast 2023 Full Year Financial Results Webcast, page-29

  1. 6,278 Posts.
    lightbulb Created with Sketch. 372
    Great post Stanjupiter…..hopefully we will eventually receive a fair assessment & a well deserved FDA approval if & when they eventually exhaust the endless ‘t crossing and pedantic i dotting ‘ delay strategies..you mentioned stakeholders….when will patients & parents emerge as one to expose this injustice ?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.